Functional Electrical Stimulation of Peripheral Muscles in Heart Failure With Preserved Left Ventricular Ejection Fraction
Heart Failure With Preserved Left Ventricular Ejection Fraction
About this trial
This is an interventional treatment trial for Heart Failure With Preserved Left Ventricular Ejection Fraction
Eligibility Criteria
Inclusion Criteria:
(i) symptoms [New York Heart Association (NYHA) class II or III] and signs typical of heart failure
(ii) left ventricular (LV) ejection fraction (LVEF) >50% and LV end-diastolic volume index <97 mL/m2
(iii) findings of left atrial (LA) dilatation (LA volume index >40mL/m2), LV hypertrophy and/or LV diastolic dysfunction [ie, mitral E/A ratio <1 or >2, mitral E/e' ratio >15 or 8-15, (A pulmonary - A mitral) duration difference >30 ms etc)
(iv) no alterations in medical therapy during the previous 4 weeks
(v) no myocardial infarction within 3 months prior to enrollment
Exclusion Criteria:
recent (≤4 weeks) heart failure decompensation
- acute coronary syndrome
- chronic inflammatory diseases and malignancies
Sites / Locations
- Attikon University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Functional electrical stimulation
Placebo
Functional electrical stimulation of lower limbs